{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:45:15Z","timestamp":1782301515893,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3075-z","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T12:49:48Z","timestamp":1523882988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients"],"prefix":"10.1186","volume":"18","author":[{"given":"Dominika","family":"Deborska-Materkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Perkowska-Ptasinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sadowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Gozdowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Ciszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Serwanska-Swietek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Domagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Miszewska-Szyszkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Sitarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jozwik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Durlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"3075_CR1","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1056\/NEJMra064928","volume":"357","author":"JA Fishman","year":"2007","unstructured":"Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601\u201314.","journal-title":"N Engl J Med"},{"key":"3075_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","volume":"4","author":"C Paya","year":"2004","unstructured":"Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Valganciclovir Solid Organ Transplant Study Group. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2004;4:611\u201320.","journal-title":"Am J Transplant"},{"key":"3075_CR3","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","volume":"6","author":"JA Khoury","year":"2006","unstructured":"Khoury JA, Storch GA, Bohl DL, Schussler RM, Torrence SM, Lockwood M, et al. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant. 2006;6:2134\u201343.","journal-title":"Am J Transplant"},{"issue":"5","key":"3075_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010;10(5):1228\u201337.","journal-title":"Am J Transplant"},{"key":"3075_CR5","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","volume":"81","author":"AP Limaye","year":"2006","unstructured":"Limaye AP, Bakthavatsalam R, Kim HW, Randolph SE, Halldorson JB, Healey PJ, et al. Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. Transplantation. 2006;81:1645\u201352.","journal-title":"Transplantation"},{"issue":"1","key":"3075_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1600-6143.2011.03766.x","volume":"12","author":"L Couzi","year":"2012","unstructured":"Couzi L, Helou S, Bachelet T, Moreau K, Martin S, Morel D, et al. High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy. Am J Transplant. 2012;12(1):202\u20139.","journal-title":"Am J Transplant"},{"issue":"suppl 4","key":"3075_CR7","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","volume":"9","author":"A Humar","year":"2009","unstructured":"Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant. 2009;9(suppl 4):S78\u201386.","journal-title":"Am J Transplant"},{"issue":"4","key":"3075_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","volume":"96","author":"CN Kotton","year":"2013","unstructured":"Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333\u201360.","journal-title":"Transplantation"},{"issue":"3","key":"3075_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.trre.2016.04.001","volume":"30","author":"J Torre-Cisneros","year":"2016","unstructured":"Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisan S, et al. Management of cytomegalovirus infection in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations. Transplant Rev. 2016;30(3):119\u201343.","journal-title":"Transplant Rev"},{"issue":"8","key":"3075_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/j.1600-6143.2008.02294.x","volume":"8","author":"GP Westall","year":"2008","unstructured":"Westall GP, Mifsud NA, Kotsimbos T. Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity. Am J Transplant. 2008;8(8):1749\u201354.","journal-title":"Am J Transplant"},{"issue":"4","key":"3075_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10875-012-9670-7","volume":"32","author":"J Carbone","year":"2012","unstructured":"Carbone J, Lanio N, Gallego A, et al. Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients. J Clin Immunol. 2012;32(4):809\u201319.","journal-title":"J Clin Immunol"},{"issue":"2","key":"3075_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcv.2012.02.020","volume":"54","author":"VC Emery","year":"2012","unstructured":"Emery VC, Asher K, de Juan Sanhuan C. Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation. J Clin Virol. 2012;54(2):125\u20139.","journal-title":"J Clin Virol"},{"key":"3075_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/383040","volume":"189","author":"FM Mattes","year":"2004","unstructured":"Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M, et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. J Infect Dis. 2004;189:1355\u201361.","journal-title":"J Infect Dis"},{"key":"3075_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1399-3062.2006.00199.x","volume":"9","author":"S Walker","year":"2007","unstructured":"Walker S, Fazou C, Crough T, Holdsworth R, Kiely P, Veale M, et al. Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERONCMV. Transpl Infect Dis. 2007;9:165\u201370.","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"3075_CR15","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/ajt.14347","volume":"17","author":"D Kumar","year":"2017","unstructured":"Kumar D, Mian M, Singer L, Humar A. An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation. Am J Transplant. 2017;17(9):2468\u201373. https:\/\/doi.org\/10.1111\/ajt.14347 .","journal-title":"Am J Transplant"},{"key":"3075_CR16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1111\/j.1600-6143.2005.00871.x","volume":"5","author":"U Sester","year":"2005","unstructured":"Sester U, Gartner BC, Wilkens H, Schwaab B, Wossner R, Kindermann I, et al. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant. 2005;5:1483\u20139.","journal-title":"Am J Transplant"},{"key":"3075_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1432-2277.2009.01017.x","volume":"23","author":"AJ Eid","year":"2010","unstructured":"Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, et al. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection. Transplant Int. 2010;23:506\u201313.","journal-title":"Transplant Int"},{"key":"3075_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.TP.0000438025.96334.eb","volume":"97","author":"MO Lopez-Oliva","year":"2014","unstructured":"Lopez-Oliva MO, Martinez V, Buitrago A, Jimenez C, Rivas B, Escuin F, et al. Pretransplant CD8 T cell response to IE-1 discriminates seropositive kidney recipients CD8+ T cell response in CMV-seropositive candidates at risk of developing CMV infection posttransplant. Transplantation. 2014;97:839\u201345.","journal-title":"Transplantation"},{"issue":"1","key":"3075_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12865-017-0194-z","volume":"18","author":"B Banas","year":"2017","unstructured":"Banas B, B\u00f6ger CA, L\u00fcckhoff G, Kr\u00fcger B, Barabas S, Batzilla J, et al. Validation of T-track\u00ae CMV to assess the functionality of cytomegalovirus-reactive cell-mediatedimmunity in hemodialysis patients. BMC Immunol. 2017;18(1):15. https:\/\/doi.org\/10.1186\/s12865-017-0194-z .","journal-title":"BMC Immunol"},{"issue":"11","key":"3075_CR20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/cid\/ciu589","volume":"59","author":"M Lucia","year":"2014","unstructured":"Lucia M, Crespo E, Melilli E, Cruzado JM, Luque S, Llaudo I, et al. Preformed frequencies of cytomegalovirus (CMV)\u2013specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients. Clin Infect Dis. 2014;59(11):1537\u201345.","journal-title":"Clin Infect Dis"},{"key":"3075_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1600-6143.2003.00647.x","volume":"5","author":"R Radha","year":"2005","unstructured":"Radha R, Jordan S, Puliyanda D, Bunnapradist S, Petrosyan A, Amet N, et al. Cellular immune responses to cytomegalovirus in renal transplant recipients. Am J Transplant. 2005;5:110\u20137.","journal-title":"Am J Transplant"},{"key":"3075_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1479-5876-6-29","volume":"6","author":"A Egli","year":"2008","unstructured":"Egli A, Binet I, Binggeli S, J\u00e4ger C, Dumoulin A, Schaub S, et al. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J Transl Med. 2008;6:29.","journal-title":"J Transl Med"},{"key":"3075_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1086\/654931","volume":"202","author":"D Abate","year":"2010","unstructured":"Abate D, Saldan A, Fiscon M, Cofano S, Paciolla A, Furian L, et al. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients. J Infect Dis. 2010;202:585\u201394.","journal-title":"J Infect Dis"},{"key":"3075_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1399-0012.2009.00976.x","volume":"24","author":"F Sund","year":"2010","unstructured":"Sund F, Lidehall AK, Claesson K, Foss A, Totterman TH, Korsgren O, et al. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study. Clin Transpl. 2010;24:401\u20139.","journal-title":"Clin Transpl"},{"key":"3075_CR25","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1111\/j.1600-6143.2011.03636.x","volume":"11","author":"G Gerna","year":"2011","unstructured":"Gerna G, Lilleri D, Chiesa A, Zelini P, Furione M, Comolli G, et al. Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. Am J Transplant. 2011;11:2463\u201371.","journal-title":"Am J Transplant"},{"key":"3075_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/TP.0b013e31823c1cd4","volume":"93","author":"LF Lisboa","year":"2012","unstructured":"Lisboa LF, Kumar D, Wilson LE, Humar A. Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation. 2012;93:195\u2013200.","journal-title":"Transplantation"},{"key":"3075_CR27","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/ajt.12256","volume":"13","author":"O Bestard","year":"2013","unstructured":"Bestard O, Lucia M, Crespo E, van Liempt B, Palacio D, Melilli E, et al. Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation. Am J Transplant. 2013;13:1793\u2013805.","journal-title":"Am J Transplant"},{"key":"3075_CR28","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1681\/ASN.2013040340","volume":"24","author":"S Shabir","year":"2013","unstructured":"Shabir S, Kaul B, Pachnio A, Bancham GD, Smith H, Chand S, et al. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation. J Am Soc Nephrol. 2013;24:1698\u2013708.","journal-title":"J Am Soc Nephrol"},{"key":"3075_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/ajt.13012","volume":"15","author":"S Cantisan","year":"2015","unstructured":"Cantisan S, Rodelo-Haad C, Paez-Vega A, Nieto A, Vaquero JM, Poyato A, et al. Factors related to the development of CMV-specific CD81T cell response in CMV-seropositive solid organ transplant candidates. Am J Transplant. 2015;15:715\u201322.","journal-title":"Am J Transplant"},{"issue":"8","key":"3075_CR30","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1128\/JCM.00563-13","volume":"51","author":"D Abate","year":"2013","unstructured":"Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, et al. Comparison of Cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV Qantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients. J Clin Microbiol. 2013;51(8):2501\u20137.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"3075_CR31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","volume":"9","author":"D Kumar","year":"2009","unstructured":"Kumar D, Chernenko S, Moussa G, Cobos I, Manuel O, Preiksaitis J, et al. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant. 2009;9(5):1214\u201322.","journal-title":"Am J Transplant"},{"key":"3075_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.vaccine.2005.08.058","volume":"24","author":"T Bauer","year":"2006","unstructured":"Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine. 2006;24:572\u20137.","journal-title":"Vaccine"},{"key":"3075_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/cid\/cis993","volume":"56","author":"O Manuel","year":"2013","unstructured":"Manuel O, Husain S, Kumar D, Zayas C, Mawhorter S, Levi ME, et al. Assessment of cytomegalovirusspecific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis. 2013;56:817\u201324.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3075_CR34","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/lt.24216","volume":"21","author":"S Sood","year":"2015","unstructured":"Sood S, Haifer C, Yu L, Pavlovic J, Gow PJ, Jones RM, et al. Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation. Liver Transpl. 2015;21(12):1478\u201385.","journal-title":"Liver Transpl"},{"key":"3075_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","volume":"2","author":"Y Lebranchu","year":"2002","unstructured":"Lebranchu Y, Bridoux F, Buchler M, Le Meur Y, Etienne I, Toupance O, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant. 2002;2:48\u201356.","journal-title":"Am J Transplant"},{"issue":"6","key":"3075_CR36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MOT.0b013e3283186bbc","volume":"13","author":"S Mawhorter","year":"2008","unstructured":"Mawhorter S, Yamani MH. Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Curr Opin Organ Transplant. 2008;13(6):581\u20135.","journal-title":"Curr Opin Organ Transplant"},{"key":"3075_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1399-3062.2003.00035.x","volume":"5","author":"K Keven","year":"2003","unstructured":"Keven K, Sahin M, Kutlay S, Sengul S, Erturk S, Ersoz S, et al. Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis. 2003;5:181.","journal-title":"Transpl Infect Dis"},{"key":"3075_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1034\/j.1399-3062.2000.020306.x","volume":"2","author":"R Corales","year":"2000","unstructured":"Corales R, Chua J, Mawhorter SD, Young JB, Starling R, Tomford JW, et al. Significant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? Transplant Infect Dis. 2000;2:133\u20139.","journal-title":"Transplant Infect Dis"},{"key":"3075_CR39","first-page":"57","volume":"21","author":"EN Broeders","year":"2008","unstructured":"Broeders EN, Wissing KM, Hazzan M, Ghisdal L, Hoang AD, Noel C, et al. Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complications. Transpl Int. 2008;21:57\u201364.","journal-title":"Transpl Int"},{"issue":"10","key":"3075_CR40","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1111\/j.1600-6143.2012.04192.x","volume":"12","author":"M Fern\u00e1ndez-Ruiz","year":"2012","unstructured":"Fern\u00e1ndez-Ruiz M, L\u00f3pez-Medrano F, Varela-Pe\u00f1a P, Lora-Pablos D, Garc\u00eda-Reyne A, Gonz\u00e1lez E, et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection. Am J Transplant. 2012;12(10):2763\u201373.","journal-title":"Am J Transplant"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3075-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T19:02:03Z","timestamp":1660935723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3075"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3075-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]},"assertion":[{"value":"3 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of Medical University of Warsaw and complied with the provisions of the Good Clinical Practice Guidelines and the Declaration of Helsinki. All patients provided written informed consent prior to participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"179"}}